Question 1 · Hard
A 64-year-old man with IgG kappa myeloma has been on lenalidomide maintenance since an autologous stem cell transplant 2 years ago. Free light chain reference intervals: kappa 3.3-19.4 mg/L, lambda 5.7-26.3 mg/L, ratio 0.26-1.65. A year ago: M-protein 2 g/L, free kappa 18 mg/L, free lambda 12 mg/L, creatinine 88 µmol/L (1.0 mg/dL). Today: M-protein still 2 g/L, free kappa 640 mg/L, free lambda 8 mg/L, creatinine 168 µmol/L (1.9 mg/dL), hemoglobin 98 g/L (9.8 g/dL), down from 128 g/L, and urine immunofixation shows free kappa. The most likely explanation is:
- ARelapse as free light chain escape
- BReduced renal clearance of light chains
- COligoclonal immune recovery after transplant
- DPolyclonal B-cell activation by infection
Show answerHide answer
Answer: A · Relapse as free light chain escape
The kappa/lambda ratio has risen from 1.5 to 80 (640 ÷ 8), with lambda suppressed, while the intact IgG M-protein has not changed: a clone has emerged that secretes only free kappa chains. This light chain escape is a recognized form of relapse, and the rising creatinine, falling hemoglobin and free kappa in the urine show that it is already causing damage. Reduced kidney clearance raises kappa and lambda together and keeps the ratio close to normal, and polyclonal activation also raises both. Oligoclonal bands after transplant appear on immunofixation and do not produce a ratio of 80. This is why myeloma is monitored with serum free light chains as well as the M-protein.
- B: Kidney impairment raises both light chains, so the ratio stays near normal.
- C: Oligoclonal bands show on immunofixation and do not give a kappa/lambda ratio of 80.
- D: Polyclonal activation raises kappa and lambda together.